A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease

Cited by (999)

Items 501–600 of 999

1. Vascular Complications of Diabetes Mellitus
   Yien Chiong, Carmella Evans‐Molina · 2014 · Springer eBooks
2. Ankle-brachial index and cardiovascular outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial
   Jinnette Dawn Abbott, Manuel S. Lombardero, Gregory W. Barsness, Ivan Pena‐Sing, Luisa Virginia Buitrón, Premranjan P. Singh, Gail Woodhead, Jean‐Claude Tardif, Sheryl F. Kelsey · 2012 · American Heart Journal
3. Personalized vascular medicine: Individualizing drug therapy
   Emil M. deGoma, Giovanni Rivera, Scott M. Lilly, M Haris U Usman, Emile R. Mohler · 2011 · Vascular Medicine
4. Trends in Characteristics and Outcomes of Hospitalized Young Patients Undergoing Coronary Artery Bypass Grafting in the United States, 2004 to 2018
   Sourbha S. Dani, Abdul Mannan Khan Minhas, Adeel Arshad, Troy Krupica, Sachin S. Goel, Salim S. Virani, Garima V. Sharma, Ron Blankstein, Michael Joseph Blaha, Sadeer G Al-Kindi et al. · 2021 · Journal of the American Heart Association
5. Update on the medical treatment of stable angina
   Jean-Louis Gayet, Franck F. Paganelli, Alain Cohen Solal · 2011 · Archives of cardiovascular diseases
6. Diabetes, Cardiovascular Risk and Nephropathy
   Allison J Hahr, Mark E. Molitch · 2010 · Cardiology Clinics
7. Gender disparity in cardiovascular disease: bias or biology?
   NANETTE KASS WENGER · 2012 · Expert Review of Cardiovascular Therapy
8. Stress Computed Tomography Myocardial Perfusion Imaging: A New Topic in Cardiology
   Sara Seitun, Margherita Castiglione Morelli, Irilda Budaj, Sara Boccalini, Athena Galletto Pregliasco, Alberto Valbusa, Filippo Cademartiri, Carlo Ferro · 2016 · Revista Española de Cardiología (English Edition)
9. Long-Term Survival Benefit of Coronary Revascularization in Patients Undergoing Stress Myocardial Perfusion Imaging
   Mario Petretta, Wanda Acampa, Stefania Daniele, Emilia Zampella, Roberta Assante, Carmela Nappi, Marco Salvatore, Alberto Cuocolo · 2015 · Circulation Journal
10. Impact of Insulin-Treated Diabetes and Hemodialysis on Long-Term Clinical Outcomes Following Sirolimus-Eluting Stent Deployment - Insights From a Sub-Study of The Cypher Stent Japan Post-Marketing Surveillance (Cypher J-PMS) Registry -
    Masato Nakamura, Hiroyoshi Yokoi, Yuji Hamazaki, Masato Watarai, Mikihiro Kijima, Kazuaki Mitsudo, The Cypher J-PMS Investigators · 2010 · Circulation Journal
11. Fractional flow reserve by computerized tomography and subsequent coronary revascularization
    René R. Sevag Packard, Dong Li, Matthew Jay Budoff, Ronald P. Karlsberg · 2016 · European Heart Journal - Cardiovascular Imaging
12. Should NICE guidelines be universally accepted for the evaluation of stable coronary disease? A debate
    Harvey S. Hecht, Leslee J. Shaw, Yellaprada Chandrashekhar, Jeroen Joost Bax, Jagat Narula · 2019 · European Heart Journal
13. Should extensive myocardial ischaemia prompt revascularization to improve outcomes in chronic coronary artery disease?
    Raymond J. Gibbons, Todd D. Miller · 2015 · European Heart Journal
14. International Participation in Cardiovascular Randomized Controlled Trials Sponsored by the National Heart, Lung, and Blood Institute
    Esther Kim, Thomas Carrigan, Venu Menon · 2011 · Journal of the American College of Cardiology
15. The role of dobutamine stress cardiovascular magnetic resonance in the clinical management of patients with suspected and known coronary artery disease
    Rolf Gebker, Cosima Jahnke, Robert Manka, Thomas Hucko, Bernhard Schnackenburg, Sebastian Kelle, Christoph Klein, Eckart Fleck, Ingo Paetsch · 2011 · Journal of Cardiovascular Magnetic Resonance
16. Can Functional Testing for Ischemia and Viability Guide Revascularization?
    Lisa Marie Mielniczuk, Gábor G. Tóth, Joe X. Xie, Bernard De Bruyne, Leslee J. Shaw, Rob S. Beanlands · 2017 · JACC. Cardiovascular imaging
17. Ten‐year Outcomes After Drug‐Eluting Stents or Bypass Surgery for Left Main Coronary Disease in Patients With and Without Diabetes Mellitus: The PRECOMBAT Extended Follow‐Up Study
    Yeongjin Jeong, Jung‐Min Ahn, Junho Hyun, Junghoon Lee, Ju Hyeon Kim, Yujin Yang, KyungJin Choe, Hanbit Park, Do‐Yoon Kang, Pil Hyung Lee et al. · 2021 · Journal of the American Heart Association
18. Complete Revascularization and Angina-Related Health Status in the ISCHEMIA Trial
    Kreton Mavromatis, Philip G. Jones, Ziad A. Ali, Gregg W. Stone, Grace M. Rhodes, Sripal Bangalore, Sean M. O’Brien, Philippe Généreux, Jennifer A. Horst, Ovidiu Dressler et al. · 2023 · Journal of the American College of Cardiology
19. Angiography Is the Gold Standard and Objective Evidence of Myocardial Ischemia Is Mandatory If Lesion Severity Is Questionable - Indication of PCI for Angiographically Significant Coronary Artery Stenosis Without Objective Evidence of Myocardial Ischemia (Pro) -
    Masato Nakamura · 2010 · Circulation Journal
20. Screening for Coronary Artery Disease in Type 2 Diabetes
    Charles T. Upchurch, Eugene J. Barrett · 2012 · The Journal of Clinical Endocrinology & Metabolism
21. Inefficacy Interim Monitoring Procedures in Randomized Clinical Trials: The Need to Report
    Edward L. Korn, Boris Freidlin · 2011 · The American Journal of Bioethics
22. Screening for coronary artery disease in asymptomatic individuals: Why and how?
    Philippe Degrell, Emmanuel Sorbets, Laurent J. Feldman, Philippe Gabríel Steg, Grégory Ducrocq · 2015 · Archives of cardiovascular diseases
23. Does Ischemia Burden in Stable Coronary Artery Disease Effectively Identify Revascularization Candidates?
    Rory Hachamovitch · 2015 · Circulation Cardiovascular Imaging
24. Comparison of Coronary Computed Tomographic Angiographic Findings in Asymptomatic Subjects With Versus Without Diabetes Mellitus
    Park, Gyung-Min, Lee, Jae-Hwan, Lee, Seung-Whan, Yun, Sung-Cheol, Kim, Young-Hak, Cho, Young-Rak, Gil, Eun Ha, Kim, Tae-Seok, Kim, Chan Joon, Cho, Jung Sun et al. · 2015 · The American Journal of Cardiology
25. Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trial
    MacDonald, Michael R., She, Lilin, Doenst, Torsten, Binkley, Philip F., Rouleau, Jean L., Tan, Ru-San, Lee, Kerry L., Miller, Alan B., Sopko, George, Szalewska, Dominika et al. · 2015 · European Journal of Heart Failure
26. Health Status and Clinical Outcomes in Older Adults With Chronic Coronary Disease
    Dan D. Nguyen, John A. Spertus, Karen P. Alexander, Jonathan D. Newman, John A. Dodson, Philip G. Jones, Susanna R. Stevens, Sean M. O’Brien, Reto Andreas Gamma, Gian Piero Perna et al. · 2023 · Journal of the American College of Cardiology
27. Predicting response to endovascular therapies: Dissecting the roles of local lesion complexity, systemic comorbidity, and clinical uncertainty
    Kumaran Kolandaivelu, Benjamin B. Leiden, Elazer Reuven Edelman · 2014 · Journal of Biomechanics
28. Clinical and prognostic value of stress echocardiography appropriateness criteria for evaluation of coronary artery disease in a tertiary referral centre
    Sanjeev Bhattacharyya, Vasileios Kamperidis, Navtej Chahal, Benoy Nalin Shah, Isabelle Roussin, Wei Li, Rajdeep Singh Khattar, Roxy Senior · 2013 · Heart
29. The BARI 2D study: A randomised trial of therapies for type 2 diabetes and coronary artery disease
    Martin K. Rutter, Richard W. Nesto · 2009 · Diabetes and Vascular Disease Research
30. Strategies for Diabetes Management: Using Newer Oral Combination Therapies Early in the Disease
    Joel Zonszein, Per‐Henrik Groop · 2016 · Diabetes Therapy
31. What constitutes an appropriate empirical trial of antianginal therapy in patients with stable angina before referral for revascularisation?
    William E. Boden, Juan Carlos Kaski, Rasha Kadem Al-Lamee, William S. Weintraub · 2022 · The Lancet
32. Kidney function modifies the selection of treatment strategies and long-term survival in stable ischaemic heart disease: insights from the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH) registry
    Jay Shavadia, Danielle A. Southern, Matthew Thomas James, Robert C. Welsh, Kevin R. Bainey · 2017 · European Heart Journal - Quality of Care and Clinical Outcomes
33. Urgent Revascularization Strategies in Patients With Diabetes Mellitus and Acute Coronary Syndrome
    Lucas C. Godoy, Patrick R. Lawler, Michael E. Farkouh, Bronwyn Hersen, José Carlos Nicolau, Vivek A. Rao · 2019 · Canadian Journal of Cardiology
34. Influence of Total Coronary Occlusion on Clinical Outcomes (from the Bypass Angioplasty Revascularization Investigation 2 DiabetesTrial)
    Abdulla A. Damluji, Sydney F. Pomenti, Archana Ramireddy, Mohammed Salim Al‐Damluji, Carlos Enrique Alfonso, Alan H. Schob, Steven P. Marso, Ian C. Gilchrist, Mauro M. Moscucci, David E. Kandzari et al. · 2016 · The American Journal of Cardiology
35. Hybrid coronary revascularization: position paper of the European Society of Cardiology Working Group on Cardiovascular Surgery and European Association of Percutaneous Cardiovascular Interventions
    Matthias Thielmann, Nikolaos E. Bonaros, Emanuele Barbato, Fabio Barili, Thierry A Folliguet, Guy Friedrich, Roman Gottardi, Jacek Legutko, Alessandro Parolari, Prakash P Punjabi et al. · 2024 · European Journal of Cardio-Thoracic Surgery
36. Long-term mortality in patients with type 2 diabetes undergoing coronary angiography: the impact of glucose-lowering treatment
    N. Saleh, Pétur Pétursson, Bo Lagerqvist, Helga Skúladóttir, Ann‐Marie Svensson, Björn Eliasson, Soffia Guðbjörnsdóttir, Katarina Eeg‐Olofsson, Anna Norhammar · 2012 · Diabetologia
37. Clinical outcomes in diabetic and non-diabetic patients with drug-eluting stents: results from the first phase of the prospective multicenter German DES.DE registry
    İbrahim Akın, Alexander Bufe, Steffen Schneider, Holger Reinecke, Lars Eckardt, Gert Richardt, Detlev Burska, Jochen Senges, Karl‐Heinz Kück, Christoph Anton Nienaber · 2010 · Clinical Research in Cardiology
38. Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus
    Awsan Noman, Karthik Balasubramaniam, M. H. A. Alhous, Kelvin Lee, P. Jesudason, Muhammad Owais Rashid, Mamas A. Mamas, Azfar Zaman · 2016 · Catheterization and Cardiovascular Interventions
39. Prognostic value of myocardial perfusion imaging performed pre-renal transplantation: post-transplantation follow-up and outcomes
    Christopher W. Ives, Wael AlJaroudi, Vineeta Kumar, Ayman Farag, Dana V. Rizk, Suzanne Oparil, Ami E. Iskandrian, Fadi G. Hage · 2018 · European Journal of Nuclear Medicine and Molecular Imaging
40. Development and validation of optimal phenomapping methods to estimate long-term atherosclerotic cardiovascular disease risk in patients with type 2 diabetes
    Matthew W. Segar, Kershaw V. Patel, Muthiah Vaduganathan, Melissa C. Caughey, Byron C. Jaeger, Mujeeb A. Basit, DuWayne L. Willett, Javed Butler, Partho P. Sengupta, Thomas J. Wang et al. · 2021 · Diabetologia
41. A calibration approach to transportability and data‐fusion with observational data
    Kevin Josey, Fan Yang, Debashis Ghosh, Sridharan Raghavan · 2022 · Statistics in Medicine
42. Management of Residual Risk in Chronic Coronary Syndromes. Clinical Pathways for a Quality-Based Secondary Prevention
    Simona Giubilato, Fabiana Lucà, Maurizio Giuseppe Abrignani, Laura Gatto, Carmelo Massimiliano Rao, Nadia Ingianni, Francesco Amico, Roberta Rossini, Giorgio Caretta, Stefano Cornara et al. · 2023 · Journal of Clinical Medicine
43. Exercise as a Therapeutic Intervention in Patients with Stable Ischemic Heart Disease: An Underfilled Prescription
    William E. Boden, Barry A. Franklin, Kathy A. Berra, William L. Haskell, Karen J. Calfas, Franklin H. Zimmerman, NANETTE KASS WENGER · 2014 · The American Journal of Medicine
44. Management of Diabetes Mellitus in Patients With Cardiovascular Disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial
    Allison B. Goldfine, Vivian Andrew Fonseca · 2010 · Circulation
45. Emerging clinical role of ranolazine in the management of angina
    Nanette Wenger · 2010 · Therapeutics and Clinical Risk Management
46. Statin and Aspirin Therapy for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus
    Jacob Allen Udell, Benjamin M. Scirica, Eugene Braunwald M. D, Itamar Raz, Philippe Gabríel Steg, Jaime A. Davidson, Boaz Hirshberg, Deepak L. Bhatt · 2012 · Clinical Cardiology
47. Impact of Chronic Kidney Disease on Long-Term Outcomes in Type 2 Diabetic Patients With Coronary Artery Disease on Surgical, Angioplasty, or Medical Treatment
    Eduardo Gomes Lima, Whady Armindo Hueb, Bernard John Gersh, Paulo Cury Rezende, Cibele Larrosa Garzillo, Desidério Favarato, Alexandre Ciappina Hueb, Rosa Maria Rahmi Garcia, José Antônio Franchini Ramires, Roberto Kalil Filho · 2016 · The Annals of Thoracic Surgery
48. A Comparison of Clinical Outcomes for Diabetic and Nondiabetic Patients Following Directional Atherectomy in the DEFINITIVE LE Claudicant Cohort
    L. Garcia, M. Jaff, K. Rocha-Singh, T. Zeller, Christopher Bosarge, Suraj Kamat, J. Mckinsey · 2015 · Journal of Endovascular Therapy
49. Comparison between the summed difference score and myocardial blood flow measured by 13N-ammonia
    Raffaele Giubbini, Alessia Peli, Elisa Milan, Roberto Sciagrà, Luca Camoni, Domenico Albano, Mattia Bertoli, Mattia Bonacina, Federica Motta, Massimo Statuto et al. · 2017 · Journal of Nuclear Cardiology
50. A Case Against Low-Volume Percutaneous Coronary Intervention Centers
    William W. O’Neill · 2009 · Circulation
51. Declining frequency of ischemia detection using stress myocardial perfusion imaging.
    A. Iskandrian, F. Hage · 2013 · Journal of the American College of Cardiology
52. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
    Roffi, Marco, Patrono, Carlo, Collet, Jean-Philippe, Mueller, Christian, Valgimigli, Marco, Andreotti, Felicita, Bax, Jeroen J., Borger, Michael A., Brotons, Carlos, Chew, Derek P. et al. · 2016 · European Heart Journal
53. Temporal trends in management and outcome of diabetic and non-diabetic patients with acute coronary syndrome (ACS): Residual risk of long-term mortality persists
    Robert Klempfner, Avishay Elis, Shlomi Matezky, Gad Keren, Arie Roth, Ariel Finkelstein, Shmuel Banai, Ilan Goldenberg, Enrique Z. Fisman, Alexander Tenenbaum et al. · 2014 · International Journal of Cardiology
54. Comparative-Effectiveness of Revascularization Versus Routine Medical Therapy for Stable Ischemic Heart Disease: A Population-Based Study
    Harindra Channa Wijeysundera, Maria C. Bennell, Feng Qiu, Dennis T. Ko, Jack V. Tu, Duminda Nalaka Wijeysundera, Peter C. Austin · 2014 · Journal of General Internal Medicine
55. Screening for coronary artery disease in patients with type 2 diabetes: a meta-analysis and trial sequential analysis
    Dimitris Rucks Varvaki Rados, Lana Catani Ferreira Pinto, Cristiane Bauermann Leitão, Jorge Luiz Gross · 2017 · BMJ Open
56. 2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases
    Chern‐En Chiang, Shih-Yi Lin, Tsung‐Hsien Lin, Tzung‐Dau Wang, Hung‐I Yeh, Jung‐Fu Chen, Chia‐Ti Tsai, Yi-Jen Hung, Yi‐Heng Li, Ping‐Yen Liu et al. · 2018 · Journal of the Chinese Medical Association
57. Qing-Xin-Jie-Yu Granule for patients with stable coronary artery disease (QUEST Trial): A multicenter, double-blinded, randomized trial
    Jingen Li, Z Gao, Lijing Zhang, Shengyao Li, Qiaoning Yang, Qinghua Shang, Xiang Gao, Hua Qu, Jie Gao, Lixiao Shi et al. · 2019 · Complementary Therapies in Medicine
58. Long‐Term Clinical Outcomes Following Revascularization in High‐Risk Coronary Anatomy Patients With Stable Ischemic Heart Disease
    Kevin R. Bainey, Wendimagegn Ghidey Alemayehu, Robert C. Welsh, Arnav Kumar, Spencer B. King, Ajay Jayant Kirtane · 2020 · Journal of the American Heart Association
59. Efficacy of antihyperglycemic therapies on cardiovascular and heart failure outcomes: an updated meta-analysis and meta-regression analysis of 35 randomized cardiovascular outcome trials
    Masashi Hasebe, Satoshi Yoshiji, Yamato Keidai, Hiroto Minamino, Takaaki Murakami, Daisuke Tanaka, Yoshihito Fujita, Norio Harada, Akihiro Hamasaki, Nobuya Inagaki · 2023 · Cardiovascular Diabetology
60. Overcoming Obstacles in Risk Factor Management in Type 2 Diabetes Mellitus
    Yehuda Handelsman, Paul S. Jellinger · 2011 · Journal of Clinical Hypertension
61. Glycemic control and use of A1c in primary care patients with type 2 diabetes mellitus
    Margarita Alonso-Fernández, José Mancera‐Romero, José Javier Mediavilla Bravo, José Manuel Comas-Samper, Flora López‐Simarro, M.P. Pérez-Unanua, Jesús Iturralde-Iriso · 2015 · Primary care diabetes
62. Modification of treatment strategy after FFR measurement: CVIT-DEFER registry
    Masato Nakamura, Masakazu Yamagishi, Takafumi Ueno, Kazuhiro Hara, Sugao Ishiwata, Tomonori Itoh, Ichiro Hamanaka, Tetsuzo Wakatsuki, Teruyasu Sugano, Kazuya Kawai et al. · 2014 · Cardiovascular Intervention and Therapeutics
63. Acute consequences of hypoglycaemia in diabetic patients
    S. Halimi · 2010 · Diabetes & Metabolism
64. Coronary Revascularization in the Diabetic Patient
    Johanne Silvain, Jean-Baptiste Vignalou, Olivier Barthélémy, Mathieu Kernéis, Jean‐Philippe Collet, Gilles Montalescot · 2014 · Circulation
65. Effects on All-cause Mortality and Cardiovascular Outcomes in Patients With Type 2 Diabetes by Comparing Insulin With Oral Hypoglycemic Agent Therapy: A Meta-analysis of Randomized Controlled Trials
    Juan Li, Yuzhen Tong, Yuwei Zhang, Lizhi Tang, Qingguo Lv, Fang Zhang, Ruijie Hu, Nanwei Tong · 2016 · Clinical Therapeutics
66. Individualized Angiotensin‐Converting Enzyme (ACE)‐Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model
    Rohit M. Oemrawsingh, K. Martijn Akkerhuis, Laura C. van Vark, Ken Redekop, Goran Rudež, Willem J. Remme, Michel E. Bertrand, Kim Michael Fox, Roberto Ferrari, A.H. Jan Danser et al. · 2016 · Journal of the American Heart Association
67. Transient Ischemic Dilation in Patients With Diabetes Mellitus
    Mario Petretta, Wanda Acampa, Stefania Daniele, Maria Piera Petretta, Monica Plaitano, Alberto Cuocolo · 2013 · Circulation Cardiovascular Imaging
68. Does Treatment of Impaired Glucose Tolerance Improve Cardiovascular Outcomes in Patients with Previous Myocardial Infarction?
    ABC investigators, Masanori Asakura, Jiyoong Kim, Hiroshi Asanuma, Toshimitsu Hamasaki, Kengo Tsukahara, Yorihiko Higashino, Tetsuya Ishikawa, Yasuharu Nakama, Shinji Koba et al. · 2017 · Cardiovascular Drugs and Therapy
69. Electrocardiographic predictors of cardiovascular events in patients at high cardiovascular risk: a multicenter study.
    Rungroj Krittayaphong, Muenpetch Muenkaew, Polakit Chiewvit, Nithima Chaowalit Ratanasit, Yodying Kaolawanich, Arintaya Phrommintikul · 2019 · PubMed Central
70. Antidiabetic drugs and blood pressure changes
    Ιoannis Ilias, Costas Thomopoulos, Helena Michalopoulou, George Bazoukis, Costas P. Tsioufis, Thomas Makris · 2020 · Pharmacological Research
71. Myocardial perfusion scintigraphy for risk stratification of patients with coronary artery disease: the AMICO registry
    Alessia Gimelli, Nicola Riccardo Pugliese, Ronny R. Buechel, Michele Alessandro Coceani, Alberto Clemente, Philipp Antonio Kaufmann, Paolo Marzullo · 2020 · European Heart Journal - Cardiovascular Imaging
72. Revascularization treatment of stable coronary artery disease
    Michael Magro, Scot Garg, Patrick W.J.C. Serruys · 2011 · Expert Opinion on Pharmacotherapy
73. Long-term clinical outcomes of patients with coronary chronic total occlusion treated with percutaneous coronary intervention versus medical therapy according to presence of diabetes mellitus
    Ki Hong Choi, Jeong Hoon Yang, Young Bin Song, Joo‐Yong Hahn, Jin‐Ho Choi, Hyeon‐Cheol Gwon, Sang Hoon Lee, Seung‐Hyuk Choi · 2017 · EuroIntervention
74. Management of refractory angina in the contemporary era
    Debabrata Mukherjee · 2013 · European Heart Journal
75. Undiagnosed coronary artery disease in long-term type 1 diabetes. The Dialong study
    Kristine Bech Holte, Mona Svanteson, Kristian Folkvord Hanssen, Ylva Haig, Svein Solheim, Tore Julsrud Berg · 2019 · Journal of Diabetes and its Complications
76. Blood residence time to assess significance of coronary artery stenosis
    Javad Hashemi, Shesh Nath Rai, Shahab Ghafghazi, Robert Eric Berson · 2020 · Scientific Reports
77. Clinical Phenotypes in Patients With Type 2 Diabetes Mellitus: Characteristics, Cardiovascular Outcomes and Treatment Strategies
    Pishoy Gouda, Sijia Zheng, Tricia M. Peters, Marat Fudim, Varinder K. Randhawa, Justin Adrian Ezekowitz, Thomas A. Mavrakanas, Nadia Giannetti, Michael A. Tsoukas, Renato D. Lópes et al. · 2021 · Current Heart Failure Reports
78. Comorbid Heart Failure and Renal Impairment: Epidemiology and Management
    Pupalan Iyngkaran, Merlin C. Thomas, William Majoni, Nagesh S. Anavekar, Claudio Ronco · 2012 · Cardiorenal Medicine
79. Long-term analysis of left ventricular ejection fraction in patients with stable multivessel coronary disease undergoing medicine, angioplasty or surgery: 10-year follow-up of the MASS II trial
    Cibele Larrosa Garzillo, Whady Armindo Hueb, Bernard John Gersh, Eduardo Gomes Lima, Paulo Cury Rezende, Alexandre Ciappina Hueb, Ricardo D’Oliveira Vieira, Desidério Favarato, Alexandre C. Pereira, Paulo Rogério Soares et al. · 2013 · European Heart Journal
80. Diabetes and Adverse Cardiovascular Outcomes in Patients with Acute Coronary Syndrome - Data from Taiwan's Acute Coronary Syndrome Full Spectrum Data Registry.
    Cheng-Chun Wei, Kou Gi Shyu, Jun Cheng, Hei Ming Lo, Chiung‐Zuan Chiu · 2016 · Europe PMC (PubMed Central)
81. Optimal Medical Therapy for Known Coronary Artery Disease
    Raymond J. Gibbons, Todd D. Miller · 2017 · JAMA Cardiology
82. Cardiovascular Screening for the Asymptomatic Patient with Diabetes: More Cons Than Pros
    Konstantinos Makrilakis, Stavros Liatis · 2017 · Journal of Diabetes Research
83. Impact of diabetes mellitus in patients undergoing contemporary percutaneous coronary intervention: Results from a Korean nationwide study
    Yujin Yang, Gyung‐Min Park, Seungbong Han, Yong‐Giun Kim, Jon Suh, Hyun Woo Park, Ki‐Bum Won, Soe Hee Ann, Shin‐Jae Kim, Dae‐Won Kim et al. · 2018 · PLoS ONE
84. A Review of Cardiovascular Outcomes Trials of Glucose-Lowering Therapies and Their Effects on Heart Failure Outcomes
    Michael E. Nassif, Mikhail Kosiborod · 2019 · The American Journal of Cardiology
85. Glycemic Control in Coronary Revascularization
    Francisco Ujueta, Ephraim N. Weiss, Steven P. Sedlis, Binita Shah · 2016 · Current Treatment Options in Cardiovascular Medicine
86. Developmental actions of natriuretic peptides in the brain and skeleton
    James A. Waschek · 2004 · Cellular and Molecular Life Sciences
87. Coronary Revascularization in Women
    Gina Price Lundberg, Spencer B. King · 2012 · Clinical Cardiology
88. Acute Coronary Syndrome in Patients with Diabetes Mellitus: Perspectives of an Interventional Cardiologist
    Saurabh Sanon, Rikesh Patel, Carrie Eshelbrenner, Vani P. Sanon, Mohsin Alhaddad, RENE A. OLIVEROS, Son V. Pham, ROBERT J. CHILTON · 2012 · The American Journal of Cardiology
89. The cardiovascular effects of insulin
    Lisa M. Younk, Elizabeth Mary Lamos, Stephen N. Davis · 2014 · Expert Opinion on Drug Safety
90. Eurasian Guidelines for the diagnostics and management of stable coronary artery disease (2020-2021)
    Karpov IuA, О. Л. Барбараш, Alla A. Boshchenko, В. В. Кашталап, Valery V. Kukharchuk, В. М. Миронов, Е. П. Панченко, Maria M. Ruda, A. N. Samko, Г. Н. Соболева et al. · 2021 · Eurasian heart journal
91. CX3CL1 Worsens Cardiorenal Dysfunction and Serves as a Therapeutic Target of Canagliflozin for Cardiorenal Syndrome
    Cankun Zheng, Wanling Xuan, Zhenhuan Chen, Rui Zhang, Xiaoxia Huang, Yingqi Zhu, Siyuan Ma, Kaitong Chen, Lu Chen, Mingyuan He et al. · 2022 · Frontiers in Pharmacology
92. Angina in 2022: Current Perspectives
    Roberto Manfredi, Monica Verdoia, Paolo Compagnucci, Alessandro Barbarossa, Giulia Stronati, Michela Casella, Antonio Dello Russo, Federico Guerra, Giuseppe Ciliberti · 2022 · Journal of Clinical Medicine
93. Cardiovascular defense challenges at the basic, clinical, and population levels
    Jason Ciril Kovacic, Jose Maria Castellano, Valentı́n Fuster · 2012 · Annals of the New York Academy of Sciences
94. Is cardiac catheterization necessary before initial management of patients with stable ischemic heart disease? Results from a Web-based survey of cardiologists
    David Joel Maron, Gregg W. Stone, Daniel S. Berman, G.B. John Mancini, Theresa A Scott, Daniel W. Byrne, Frank E. Harrell, Leslee J. Shaw, Rory Hachamovitch, William E. Boden et al. · 2011 · American Heart Journal
95. The Utility of Cardiopulmonary Exercise Testing to Detect and Track Early-Stage Ischemic Heart Disease
    Sundeep Chaudhry, Ross A Arena, James E. Hansen, Gregory D. Lewis, JONATHAN N. MYERS, Laurence S. Sperling, Brian D. LaBudde, Karlman Wasserman · 2010 · Mayo Clinic Proceedings
96. Role of Coronary Angiography in the Assessment of Cardiovascular Risk in Kidney Transplant Candidates
    David M. Mann, Sonalis Fernandez, Zahidul H. Mondal, David A. Laskow, Adena J. Osband, Meelie A. DebRoy, Jonathan Lebowitz, James Coromilas, Tudor Dumitru Vagaonescu, Abel E. Moreyra et al. · 2016 · The American Journal of Cardiology
97. Comprehensive Cardiovascular Risk Reduction and Cardiac Rehabilitation in Diabetes and the Metabolic Syndrome
    Robert E. Heinl, Devinder Singh Dhindsa, Elliot N. Mahlof, William M. Schultz, Johnathan C. Ricketts, Tina Varghese, Amir Esmaeeli, Marc Allard‐Ratick, Anthony J. Millard, Heval Mohamed Kelli et al. · 2016 · Canadian Journal of Cardiology
98. Screening for the Presence of Cardiovascular Disease
    Paul Poirier, Olivier Francois Bertrand, Jonathon Leipsic, G.B. John Mancini, Paolo Raggi, André Roussin · 2018 · Canadian Journal of Diabetes
99. Improved regional myocardial blood flow and flow reserve after coronary revascularization as assessed by serial 15O-water positron emission tomography/computed tomography
    Tadao Aikawa, Masanao Naya, Kazuhiro Koyanagawa, Osamu Manabe, Masahiko Obara, Keiichi Magota, Noriko Oyama‐Manabe, Nagara Tamaki, Toshihisa Anzai · 2019 · European Heart Journal - Cardiovascular Imaging
100. Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention
     Joe X. Xie, Elise C. Gunzburger, Lindsay Kaun, Mary E. Plomondon, Anna E. Barón, Stephen W. Waldo, Salim S. Virani, Thomas M. Maddox, Kreton Mavromatis · 2019 · Circulation Cardiovascular Quality and Outcomes